CorNeat Vision

Season’s Greetings from CorNeat Vision! ❄️ This year we’ve created a special “Season’s Greetings” card for our patients who regained their sight and independence... 🤩

Our artificial cornea and flagship device, the CorNeat KPro, is now on display at the Israeli Innovation Expo! A must for every entrepreneur visiting the startup nation. Thanks Mai Akunis-Hermann from our marketing team for the great work in planning and executing an impressive stand featuring our flagship device along with an interactive station highlighting its illustrious journey. #innovation #cornea #opthalmology

The CorNeat KPro RESEE trial is ramping up rapidly, with nine sites on three continents currently recruiting patients. Clinical sites in Israel, France, and Canada are already doing the unimaginable and reverting corneal blindness! Additional sites in these countries, as well as sites in India and the Netherlands, will be implanting the CorNeat KPro in the next couple of months. Early follow-ups show very promising results 👏 🎉 ✨ Fondation Adolphe de Rothschild CHU de Montpellier Beilinson - Rabin Medical Center Shaare Zedek Medical Center, Jerusalem The University of British Columbia University Health Network Amsterdam UMC AIIMS (All India Institute of Medical Sciences, New Delhi) Dr. Shroff #blindness #returningsight #startup

We are proud and excited to share that the CorNeat KPro, our innovative synthetic cornea, is highlighted in the prestigious Corneal Physician magazine 📰 ✨. This esteemed publication releases three exclusive issues annually and reaches over 15,000 ophthalmologists across the U.S. “The CorNeat KPro provides patients with a physiological field of view and excellent visual performance. It offers a valuable treatment option for patients with specific eye conditions, providing renewed independence and quality of life. By replacing the opaque and damaged cornea with a clear and optimal optical lens, patients can achieve their full visual potential, assuming no other pathologies compromise their vision.” To read the full article, click below ⬇️

The CorNeat KPro exhibit at The Peres Center for Peace and Innovation is now open! 🎉👏 As proud members of the Israeli Innovation Dream Team, we are dedicated to our mission and invite everyone to visit. The CorNeat KPro, our flagship product, is an artificial cornea currently in the clinical stage. It offers a groundbreaking solution for corneally blind patients, allowing them to fully restore their vision through a simple surgical procedure, eliminating the need for donor tissue. 🧿 ✨ #innovation #startup #blindness

Blindness Awareness Month reminds us of the invaluable gift of sight! At CorNeat Vision, we are dedicated to combating global corneal blindness and preventing vision loss in severe and refractory glaucoma patients. Follow our journey as the RESEE trial progresses, showcasing how our artificial cornea, the CorNeat KPro, is transforming lives worldwide. We’re also thrilled to announce that our glaucoma drainage device, the CorNeat eShunt, is nearing the clinical phase, bringing new hope to patients suffering from glaucoma. Stay tuned for more updates on our innovative solutions! 👁️✨ #BlindnessAwarenessMonth #InnovationinSight #GlaucomaTreatment

Want to hear more from CorNeat Vision? 🧿 Make sure you subscribe and register to our bi-annual newsletter 📰 ! We recently sent one out, with plenty of interesting tidbits and updates about the company. What are you waiting for!? Link to register in the first comment 🔔

10/10 Vision – World Sight Day CorNeat Vision’s RESEE clinical trial brings forth amazing results thus far! Three months ago, our first RESEE patient regained his sight at Fondation Adolphe de Rothschild, thanks to our artificial cornea, the CorNeat KPro. Following 20 years of unsuccessful corneal transplantations, living the last three years in complete blindness, this patient can now see perfectly. Below you can see the patient’s eye prior to the implantation (bottom left) and his eye today (furthest right). Truly remarkable! Several more patients are planned to regain their sight in the coming months as eight additional RESEE sites are set to initiate in Israel, Canada, the Netherlands, India and of course France! #WorldSightDay #Cornea #Ophthalmology

Join Almog Aley-raz, CEO and VP R&D at CorNeat Vision, as he discusses the company’s innovative medical devices in a session titled “Permanent Tissue-Integrating Ophthalmic Implants; Cutting Edge Research,” taking place at Pan Ophthalmologica, this Thursday, October 10th. This is a prestigious global webinar meant for ophthalmologists. Participation is free – register to hear more about our medical devices! https://lnkd.in/em949mqT #innovation #medicaldevices #ophthalmology

It’s been one year since October 7th. We pray that this year will see the safe return of the hostages, as well as the return of the displaced citizens of northern and southern Israel back to their homes. We pray for this war to end, and for peace to come and engulf the region. #bringthemhome